Skip to content
TheChatArchiveThe Chat Archive
Mistralmistral-small-3.1-24b-instruct-2503· Mistral AIHugging Face LMArena Human Preference 140K

Using the following user story and AC, please revise and expand the acceptance…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Googlegemma-3n-e4b-it’s answer.
  1. User

    Using the following user story and AC, please revise and expand the acceptance criteria:As a data scientist, I want to continue work on OCT images for predicting MCI. AC: Using baseline and follow up images for only those with follow up data, find key differences/biomarkers (if there are any) and continue to develop a model for predicting MCI

  2. Mistral Assistant

    To create a more comprehensive and detailed set of acceptance criteria for the user story, we need to break down the tasks and specify the expected outcomes. Here is a revised and expanded version of the acceptance criteria:

    Acceptance Criteria:

    1. Data Preparation:

      • AC 1.1: Ensure that the dataset includes both baseline and follow-up OCT (Optical Coherence Tomography) images for patients with follow-up data.
      • AC 1.2: Verify that the dataset is clean and free of missing or corrupted images.
      • AC 1.3: Normalize the OCT images to a standard format and resolution to ensure consistency.
    2. Data Segmentation:

      • AC 2.1: Segment the OCT images to identify key regions of interest (e.g., retinal layers, optic nerve head).
      • AC 2.2: Ensure that the segmentation process is automated and reproducible.
    3. Feature Extraction:

      • AC 3.1: Extract relevant features from the segmented OCT images, such as thickness measurements, texture features, and structural integrity.
      • AC 3.2: Compare baseline and follow-up features to identify potential biomarkers for MCI (Mild Cognitive Impairment).
    4. Biomarker Identification:

      • AC 4.1: Use statistical methods to determine if there are significant differences between baseline and follow-up features.
      • AC 4.2: Identify key biomarkers that show consistent differences between patients who develop MCI and those who do not.
      • AC 4.3: Validate the identified biomarkers using a separate validation dataset.
    5. Model Development:

      • AC 5.1: Develop a predictive model using machine learning algorithms to classify patients based on the identified biomarkers.
      • AC 5.2: Train the model using a subset of the dataset and evaluate its performance using cross-validation.
      • AC 5.3: Ensure that the model's performance metrics (e.g., accuracy, precision, recall, F1-score) meet predefined thresholds.
    6. Model Evaluation:

      • AC 6.1: Evaluate the model's performance on a separate test dataset to ensure generalizability.
      • AC 6.2: Conduct sensitivity analysis to understand the impact of different features on the model's predictions.
      • AC 6.3: Document the model's limitations and potential areas for improvement.
    7. Reporting and Documentation:

      • AC 7.1: Prepare a detailed report summarizing the findings, including the identified biomarkers and model performance.
      • AC 7.2: Document the data preprocessing steps, feature extraction methods, and model development process.
      • AC 7.3: Provide visualizations and plots to illustrate the key findings and model performance.
    8. Ethical and Privacy Considerations:

      • AC 8.1: Ensure that all data handling and processing comply with relevant ethical guidelines and privacy regulations.
      • AC 8.2: Anonymize patient data to protect privacy and confidentiality.

    By expanding the acceptance criteria in this manner, we provide a clear roadmap for the data scientist to follow, ensuring that all necessary steps are covered and that the final deliverables meet the required standards.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.